X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Newspaper Article (116) 116
Journal Article (72) 72
Publication (14) 14
Book Chapter (2) 2
Trade Publication Article (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44) 44
index medicus (33) 33
male (31) 31
female (30) 30
middle aged (28) 28
adult (22) 22
aged (19) 19
cancer (19) 19
athletes (18) 18
carp (18) 18
aged, 80 and over (15) 15
hematology (14) 14
oncology (14) 14
article (12) 12
surgery (11) 11
disease-free survival (10) 10
analysis (9) 9
fishing (9) 9
head (9) 9
adolescent (8) 8
follow-up studies (8) 8
medicine, general & internal (8) 8
survival (8) 8
treatment outcome (8) 8
care and treatment (7) 7
kaplan-meier estimate (7) 7
mutation (7) 7
otorhinolaryngology (7) 7
professional baseball (7) 7
retrospective studies (7) 7
young adult (7) 7
abridged index medicus (6) 6
leukemia (6) 6
adenoid cystic carcinoma (5) 5
carcinoma (5) 5
carcinoma, squamous cell - pathology (5) 5
chemotherapy (5) 5
clinical trials (5) 5
head and neck cancer (5) 5
hematology, oncology and palliative medicine (5) 5
multiple myeloma (5) 5
prognosis (5) 5
proportional hazards models (5) 5
therapy (5) 5
tournaments & championships (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
bortezomib (4) 4
canals (4) 4
carcinoma, adenoid cystic - pathology (4) 4
double-blind method (4) 4
drug therapy (4) 4
head and neck neoplasms - pathology (4) 4
leukemia, myeloid, acute - genetics (4) 4
mortality (4) 4
neoplasm staging (4) 4
new zealand (4) 4
patient outcomes (4) 4
prognostic-factors (4) 4
radiation (4) 4
radiotherapy (4) 4
rituximab (4) 4
salivary gland (4) 4
survival analysis (4) 4
survival rate (4) 4
animals (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
bone marrow (3) 3
carcinoma, adenoid cystic - mortality (3) 3
carcinoma, squamous cell - mortality (3) 3
carcinoma, squamous cell - therapy (3) 3
care (3) 3
cells (3) 3
child (3) 3
cytogenetics (3) 3
dentistry, oral surgery & medicine (3) 3
distant metastasis (3) 3
dna copy number variations (3) 3
dna mutational analysis (3) 3
dosage and administration (3) 3
experience (3) 3
gene (3) 3
genetics & heredity (3) 3
genomics (3) 3
head and neck neoplasms - surgery (3) 3
human-papillomavirus (3) 3
leukemia, lymphocytic, chronic, b-cell - drug therapy (3) 3
lymphoma (3) 3
mouth neoplasms - pathology (3) 3
neck (3) 3
neoplasm invasiveness (3) 3
oropharyngeal cancer (3) 3
outcomes (3) 3
patients (3) 3
quality of life (3) 3
quality-of-life (3) 3
radiotherapy, adjuvant (3) 3
research (3) 3
risk factors (3) 3
squamous cell carcinoma (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2016, Volume 374, Issue 23, pp. 2209 - 2221
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 17, pp. 1621 - 1634
The addition of the oral proteasome inhibitor ixazomib to a regimen of lenalidomide plus dexamethasone led to a significant prolongation of progression-free... 
SUPERIORITY | MEDICINE, GENERAL & INTERNAL | CARFILZOMIB | RANDOMIZED PHASE-3 | THERAPY | PROTEASOME INHIBITOR MLN9708 | QUALITY-OF-LIFE | BORTEZOMIB | THALIDOMIDE | ANTITUMOR-ACTIVITY | TRANSPLANTATION | Glycine - analogs & derivatives | Glycine - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Boron Compounds - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Exanthema - chemically induced | Aged, 80 and over | Adult | Glycine - administration & dosage | Dexamethasone - administration & dosage | Double-Blind Method | Administration, Oral | Kaplan-Meier Estimate | Proportional Hazards Models | Thrombocytopenia - chemically induced | Thalidomide - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Boron Compounds - adverse effects | Aged | Care and treatment | Dosage and administration | Dexamethasone | Multiple myeloma | Thrombocytopenia | Inhibitor drugs | Risk groups | Drug therapy | Peripheral neuropathy | Survival | Patients | Drug dosages | Proteasome inhibitors | Quality of life | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
by Agrawal, Nishant and Akbani, Rehan and Aksoy, B. Arman and Ally, Adrian and Arachchi, Harindra and Asa, Sylvia L and Auman, J. Todd and Balasundaram, Miruna and Balu, Saianand and Baylin, Stephen B and Behera, Madhusmita and Bernard, Brady and Beroukhim, Rameen and Bishop, Justin A and Black, Aaron D and Bodenheimer, Tom and Boice, Lori and Bootwalla, Moiz S and Bowen, Jay and Bowlby, Reanne and Bristow, Christopher A and Brookens, Robin and Brooks, Denise and Bryant, Robert and Buda, Elizabeth and Butterfield, Yaron S.N and Carling, Tobias and Carlsen, Rebecca and Carter, Scott L and Carty, Sally E and Chan, Timothy A and Chen, Amy Y and Cherniack, Andrew D and Cheung, Dorothy and Chin, Lynda and Cho, Juok and Chu, Andy and Chuah, Eric and Cibulskis, Kristian and Ciriello, Giovanni and Clarke, Amanda and Clayman, Gary L and Cope, Leslie and Copland, John A and Covington, Kyle and Danilova, Ludmila and Davidsen, Tanja and Demchok, John A and DiCara, Daniel and Dhalla, Noreen and Dhir, Rajiv and Dookran, Sheliann S and Dresdner, Gideon and Eldridge, Jonathan and Eley, Greg and El-Naggar, Adel K and Eng, Stephanie and Fagin, James A and Fennell, Timothy and Ferris, Robert L and Fisher, Sheila and Frazer, Scott and Frick, Jessica and Gabriel, Stacey B and Ganly, Ian and Gao, Jianjiong and Garraway, Levi A and Gastier-Foster, Julie M and Getz, Gad and Gehlenborg, Nils and Ghossein, Ronald and Gibbs, Richard A and Giordano, Thomas J and Gomez-Hernandez, Karen and Grimsby, Jonna and Gross, Benjamin and Guin, Ranabir and Hadjipanayis, Angela and Harper, Hollie A and Hayes, D. Neil and Heiman, David I and Herman, James G and Hoadley, Katherine A and Hofree, Matan and Holt, Robert A and Hoyle, Alan P and Huang, Mei and Huang, Franklin W and Hutter, Carolyn M and Ideker, Trey and Iype, Lisa and Jacobsen, Anders and Jefferys, Stuart R and Jones, Corbin D and Jones, Steven J.M and Kasaian, Katayoon and Kebebew, Electron and Khuri, Fadlo R and Kim, Jaegil and Kramer, Roger and ... and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
Cell, ISSN 0092-8674, 10/2014, Volume 159, Issue 3, pp. 676 - 690
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2017, Volume 4, Issue 5, pp. e225 - e236
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 10, pp. 1756 - 1765
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 25, pp. 2425 - 2437
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2016, Volume 374, Issue 23, p. 2290
The article reports on a study to evaluate the mutation of genes that takes place in cases of patients with acute myeloid leukemia (AML). The results indicate... 
Gene mutations | Genomics | Research
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 85 - 85
Over the past years it has emerged that acute myeloid leukemia (AML) is a disease often driven by multiple co-occurring genomic lesions. It is a great... 
Journal Article